RACHELLE DOODY to Antibodies, Monoclonal
This is a "connection" page, showing publications RACHELLE DOODY has written about Antibodies, Monoclonal.
Connection Strength
0.206
-
What works and what does not work in Alzheimer's disease? From interventions on risk factors to anti-amyloid trials. J Neurochem. 2020 09; 155(2):120-136.
Score: 0.114
-
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology. 2009 Dec 15; 73(24):2061-70.
Score: 0.055
-
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease. N Engl J Med. 2023 Nov 16; 389(20):1862-1876.
Score: 0.036